Search results for "Platelet"

showing 10 items of 786 documents

Platelet rich fibrin-a promising approach for tissue regeneration in oral and maxillofacial surgery: preclinical and clinical studies

2015

Pathologymedicine.medical_specialtyOtorhinolaryngologybusiness.industrymedicineOral and maxillofacial surgerySurgeryOral SurgerybusinessPlatelet-rich fibrinSurgeryInternational Journal of Oral and Maxillofacial Surgery
researchProduct

Extreme thrombocytosis as a sign of coeliac disease in the elderly: case report

2002

Increase in the number of blood platelets to over 1 000 000/mm 3 in elderly patients is generally considered secondary to a myeloproliferative or neoplastic disease. To report the case of an elderly woman hospitalized for extreme thrombocytosis associated with severe anaemia, who was found to be suffering from coeliac disease. The patient, aged 83 years, was hospitalized presenting with fatigue. Laboratory tests showed microcytic hypochromic anaemia (haemoglobin 4 g/dl) and extreme thrombocytosis (platelet count 1 400 000/mm 3 ). Physical examination was normal, with the exception of marked thinness. There was no evidence of macroscopic bleeding from the gastrointestinal or genitourinary tr…

Pathologymedicine.medical_specialtySettore MED/09 - Medicina InternaAtrophic gastritisPhysical examinationRisk AssessmentSeverity of Illness IndexCoeliac diseaseDiagnosis DifferentialHumanscoeliac disease thrombocytosis iron-deficiency anaemia elderlyMedicineIntestinal MucosaAgedAged 80 and overThrombocytosisLamina propriaHepatologymedicine.diagnostic_testThrombocytosisPlatelet Countbusiness.industryGastroenterologyPrognosismedicine.diseaseCeliac Diseasemedicine.anatomical_structureIron-deficiency anemiaSerum ironAbdomenFemalebusinessEuropean Journal of Gastroenterology & Hepatology
researchProduct

Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma-a rationale for a molecular targeting strategy?

2007

AIM: To define the (co-)expression pattern of target receptor-tyrosine-kinases (RTK) in human gastric adenocarcinoma. METHODS: The (co-)expression pattern of VEGFR1-3, PDGFRα/β and EGFR1 was analyzed by RT-PCR in 51 human gastric adenocarcinomas. In addition, IHC staining was applied for confirmation of expression and analysis of RTK localisation. RESULTS: The majority of samples revealed a VEGFR1 (98%), VEGFR2 (80%), VEGFR3 (67%), PDGFRα (82%) and PDGFRβ (82%) expression, whereas only 62% exhibited an EGFR1 expression. 78% of cancers expressed at least four out of six RTKs. While VEGFR1-3 and PDGFRα revealed a predominantly cytoplasmatic staining in tumor cells, accompanied by an additiona…

Pathologymedicine.medical_specialtyStromal cellAntineoplastic AgentsAdenocarcinomaReceptor tyrosine kinaseStomach NeoplasmsmedicineGastric mucosaHumansProtein Kinase InhibitorsbiologyReverse Transcriptase Polymerase Chain ReactionfungiGastroenterologyReceptor Protein-Tyrosine KinasesCancerGeneral Medicinemedicine.diseaseImmunohistochemistrydigestive system diseasesStainingmedicine.anatomical_structureGastric MucosaDrug Designbiology.proteinCancer researchAdenocarcinomaImmunohistochemistryDrug Therapy CombinationRapid CommunicationPlatelet-derived growth factor receptorWorld Journal of Gastroenterology
researchProduct

The Influence of PRP on Early Bone Formation in Membrane Protected Defects. A Histological and Histomorphometric Study in the Rabbit Calvaria

2011

Background: Platelet rich plasma (PRP) has been proposed to be a useful adjunct to bone grafting. Purpose: The aim of the present study was to assess new bone formation in bone regeneration procedures using platelet rich plasma (PRP) alone or in combination with autogenous bone. Materials and Methods: Four surgically created, monocortical defects 5 mm in diameter in the calvariae of 15 New Zealand rabbits were grafted with a coagulum-filled control, PRP, particulated autogenous bone alone (A), or combined with PRP (A-PRP). Results: Mean platelet concentration of 1,761,930 ± 680,200/µl was achieved (5.30 ± 2.63 × fold of baseline). Animals were sacrificed 1, 2, and 4 weeks later. Histomorpho…

Pathologymedicine.medical_specialtybusiness.industryChemistrymedicine.medical_treatmentDentistryCalvariaBone healingBone graftingResorptionBone remodelingmedicine.anatomical_structurePlatelet-rich plasmamedicinePlateletOral SurgeryBone regenerationbusinessGeneral DentistryClinical Implant Dentistry and Related Research
researchProduct

Hemostatic Alterations in Peripheral Arteriopathies

1985

The most common cause of obliterative disease in limb arteries is slowly progressive arteriosclerosis which is eventually superimposed by thrombosis.

Pathologymedicine.medical_specialtybusiness.industryMedicinePlatelet activationArteriosclerosisDiseasebusinessmedicine.diseaseThrombosisPeripheral
researchProduct

Eltrombopag treatment for severe immune thrombocytopenia during pregnancy: a case report

2021

Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia (platelet count <100 × 109/l) in the absence of other causes or disorders associated. The incidence of ITP in pregnancy is one to two cases per 1000 gestations. ITP could be diagnosed before or during pregnancy; sometimes a relapse of a previously diagnosed ITP can occur. Intravenous immune globulins (IVIg) and corticosteroids are the standard frontline therapy because of their well known safety profile either for the mother or for the neonate. Treatments for refractory patients are limited by potential fetal risk. We report the case of a patient with ITP along pregnancy, refractory…

Pediatricsmedicine.medical_specialtyAdolescenteltrombopag pregnancy.EltrombopagBenzoateschemistry.chemical_compoundRefractoryPregnancyhemic and lymphatic diseasesMedicineHumansThrombopoietin receptorFetusPregnancyPurpura Thrombocytopenic Idiopathicbusiness.industryPlatelet CountIncidence (epidemiology)Pregnancy Complications HematologicInfant NewbornHematologyGeneral Medicinemedicine.diseaseHydrazineschemistryGestationPyrazolesFemalebusinessComplicationReceptors ThrombopoietinPrimary immune thrombocytopenia
researchProduct

Consensus document on intermittent claudication from the Central European Vascular Forum 1st edition - Abano Terme (Italy) - May 2005 2nd revision - …

2008

Peripheral Vascular DiseasesLegtrainingTiclopidineAspirinAcetylsalicylic acidanticoagulant agentantithrombocytic agentconsensus document; intermittent claudicatio; training; antiplatelets' therapyintermittent claudicatioIntermittent ClaudicationSettore MED/11 - Malattie Dell'Apparato CardiovascolareClopidogrelantiplatelets' therapyIschemiaDisease ProgressionExercise TestHumansCarotid StenosisUltrasonography Doppler Colorconsensus documentPlatelet Aggregation Inhibitors
researchProduct

Serum brain-derived neurotrophic factor and platelet activation evaluated by soluble P-selectin and soluble CD-40-ligand in patients with acute myoca…

2009

Little is known about the role of neurotrophins (NT) under adult vascular homeostasis in normal and pathological conditions. The NT family, including nerve growth factor and brain-derived neurotrophic factor (BDNF) are expressed in atherosclerotic vessels. Previous studies demonstrated that plasma BDNF levels were increased in the coronary circulation in patients with unstable angina. However, the role of BDNF during the onset and evolution of unstable angina remains to be elucidated. The objective of this study was to evaluate the relationship between BDNF, functional parameters and biological markers associated with inflammatory processes and platelet activation. BDNF serum levels were as…

PharmacologyBrain-derived neurotrophic factor0303 health sciencesmedicine.medical_specialtyP-selectinUnstable anginabusiness.industry030204 cardiovascular system & hematologymedicine.disease03 medical and health sciencesCoronary circulation0302 clinical medicineNerve growth factorEndocrinologymedicine.anatomical_structureNeurotrophic factorsInternal medicineImmunologymedicinePharmacology (medical)Platelet activationMyocardial infarctionbusiness030304 developmental biologyFundamental & Clinical Pharmacology
researchProduct

The effects of the nitric oxide donors molsidomine and SIN-1 on human polymorphonuclear leucocyte functionin vitro andex vivo

1992

The nitrovasodilator and nitric oxide donor molsidomine and its metabolite SIN-I dilate vascular smooth muscle and inhibit platelet activation by increasing intracellular concentrations of cyclic GMP We have therefore studied the effects of molsidomine and SIN-I on isolated human polymorphonuclear leucocytes (PMN)in vitro andex vivo. In vitro molsidomine dose-dependently reducedβ-glucuronidase release and the generation of superoxide anions from non-activated and from FMLP- or PAF-stimulated human PMNs. SIN-1 was equally effective in reducing (β-glucuronidase release and totally inhibited oxygen radical generation at a concentration of 580 μmol · l−1. In a double-blind, placebo-controlled, …

PharmacologyMolsidomineChemistrySuperoxideMetabolitehemic and immune systemsGeneral MedicinePharmacologyNitric oxidechemistry.chemical_compoundBiochemistryIn vivomedicinePharmacology (medical)Platelet activationNitrovasodilatorEx vivomedicine.drugEuropean Journal of Clinical Pharmacology
researchProduct

Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India

2000

'Darakchasava' is a well known Indian herbal preparation of which the main ingredient is Vitis vinifera L. This 'ayurvedic' medicine is prescribed as a cardiotonic and also given for other disorders. HPLC analysis of this age old formulation revealed the presence of polyphenols like resveratrol and pterostilbene. These phenolic compounds are now known as antioxidants, cancer chemopreventive agents, and also known to reduce mortality from coronary heart disease by increasing high density lipoproteins like cholesterol and inhibiting platelet aggregation (Soleas, J.S., Diamandis, E.P., Goldberg, D.M., 1997. Resveratrol: a molecule whose time has come? and gone? Clin. Biochem. 30 (2), 91-113). …

PharmacologyPterostilbeneTraditional medicinePlant ExtractsCholesterolIndiafood and beveragesPharmacognosyResveratrolAntineoplastic Agents PhytogenicAntioxidantsMedicine Ayurvedicchemistry.chemical_compoundIngredientPhenolschemistryResveratrolPolyphenolStilbenesDrug DiscoveryHypoglycemic AgentsPlatelet aggregation inhibitorVitis viniferaChromatography High Pressure LiquidPlatelet Aggregation InhibitorsJournal of Ethnopharmacology
researchProduct